ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,487.03
0.00%
US Tech 100
19,498.80
0.47%
다우존스 지수
38,834.86
0.00%
Bitcoin
65,916.51
1.46%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Bicycle Therapeutics PLC (BCYC)

  7. Bicycle Therapeutics PLC (BCYC) 뉴스

BCYC Bicycle Therapeutics PLC

20.75
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:39:58
15분 지연
기업명 주식 심볼 시장 주식 타입
Bicycle Therapeutics PLC BCYC 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 20.75 20:39:58
개장가 저가 고가 종가 전일 종가
20.75
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
19/06/202405:18EDGAR2Form 8-K - Current report
19/06/202405:14EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
03/06/202420:00BWBicycle Therapeutics to Participate in Upcoming Investor..
24/05/202406:05BWBicycle Therapeutics to Present Pharmacokinetic and Safety..
24/05/202405:26EDGAR2Form 8-K - Current report
23/05/202420:00BWBicycle Therapeutics Announces $555 Million Private..
17/05/202405:01EDGAR2Form 8-K - Current report
02/05/202420:00BWBicycle Therapeutics Reports Recent Business Progress and..
24/04/202423:05BWBicycle Therapeutics Announces Two Abstracts Accepted for..
02/04/202420:00BWBicycle Therapeutics to Participate in the 23rd Annual..
06/03/202406:35BWBicycle Therapeutics to Present at the AACR Annual Meeting..
28/02/202421:00BWBicycle Therapeutics to Participate in Upcoming Investor..
22/02/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/02/202422:38EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/02/202421:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/02/202421:05EDGAR2Form 8-K - Current report
20/02/202421:05BWBicycle Therapeutics Reports Recent Business Progress and..
15/02/202406:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202422:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202421:00BWBicycle Therapeutics to Participate in the Oppenheimer 34th..
05/01/202408:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:35EDGAR2Form 144 - Report of proposed sale of securities
04/01/202406:34EDGAR2Form 144 - Report of proposed sale of securities
04/01/202406:32EDGAR2Form 144 - Report of proposed sale of securities
04/01/202406:28EDGAR2Form 144 - Report of proposed sale of securities
14/12/202321:05EDGAR2Form 8-K - Current report
14/12/202321:00BWBicycle Therapeutics Provides Data Updates for Three..
30/11/202321:00BWBicycle Therapeutics to Host R&D Day on December 14
02/11/202320:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202320:05EDGAR2Form 8-K - Current report
02/11/202320:00BWBicycle Therapeutics Reports Recent Business Progress and..
30/10/202320:00BWBicycle Therapeutics to Participate in Upcoming Investor..
19/10/202320:00BWBicycle Therapeutics Selected to Participate in FDA Program..
19/10/202317:00GLOBEMacomics Announces the Appointment of Kevin Lee as..
06/10/202306:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202306:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202306:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202306:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202306:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202306:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:07EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
BCYC
Bicycle Therapeutics
BIT
P1SOA4
BNP Paribas Issuance
USOTC
TTGPF
TT Electronics (PK)
NYSE
FICO
Fair Isaac
USOTC
PPMD
Protide Pharmaceuticals (GM)
LSE
NETD
Netdimensions
BIT
UC4VDK
Unicredit Bank
NASDAQ
SFST
Southern First Bancshares
BIT
S31932
Societe Generale Effekten
LSE
51RR
Anz Bank 27
NYSE
JPM
JP Morgan Chase
TSXV
CPE.H
LSE
96BH
Fed Uae 61 A
EU
FR2CIBFS5325
Credit Agricole CIB FCIA...
BITMOT
875006
Eu Tf 3,375% Ap32 Eur
USOTC
ESGH
ESG (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유